-+ 0.00%
-+ 0.00%
-+ 0.00%

AKESO ANNOUNCES NMPA ACCEPTANCE OF SNDA FOR IVONESCIMAB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE BILIARY TRACT CANCER

Reuters·11/17/2026 03:32:01